| 词条 | Martin Glennie |
| 释义 |
CareerGlennis earned his BSc and PhD at the University of Southampton, and is the current Head of the Cancer Sciences Unit there.[1] Glennie is on the editorial board of the scientific journal mAbs (monoclonal antibodies) published by the Taylor & Francis Group.[2] Public media interestThe clinical trial of an anti-CD40 monoclonal antibody chiLOB7/4 developed in Glennie's laboratory was reported by The Daily Telegraph in August 2013.[3] Glennie stressed that “Ipilimumab works by taking the brakes off part of the immune system called T cells, while our compound revs up the T cells – it is like giving them a caffeine hit.".[3] Personal lifeGlennie is a keen angler, winning second prize (Lupa cup) in the Baltimore Deep Sea angling Festival 2014, South West Ireland.[4] References1. ^1 {{cite web|title=University of Southampton Faculty of Medicine Staff page|url=http://www.southampton.ac.uk/medicine/about/staff/mjg.page|publisher=University of Southampton|accessdate=11 December 2014}} {{authority control}}{{DEFAULTSORT:Glennie, Martin}}2. ^{{cite web|title=mAbs editorial board|url=http://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=kmab20#.VIoYdDGsVic|accessdate=11 December 2014}} 3. ^1 {{cite news|title=New Immunity Boosting Drug Helps Body Kill Cancer|url=https://www.telegraph.co.uk/health/healthnews/10235296/New-immunity-boosting-drug-helps-body-kill-cancer.html|accessdate=11 December 2014|date=2013-08-11|last1=Gray|first1=Richard}} 4. ^{{cite web|title=Baltimore Deep Sea Angling Festival 2014|url=http://www.baltimoreseaangling.com/|accessdate=11 December 2014}} 5 : Year of birth missing (living people)|Living people|British chemists|Academics of the University of Southampton|Alumni of the University of Southampton |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。